Rocket Lab Corporation has upgraded its stock to Buy after a recent price drop, supported by a strong backlog of $2.36 billion, up 137% year-over-year. The company’s growth is fueled by strategic acquisitions like Mynaric, Motiv Space Systems, and Iridium, which enhance its vertically integrated space capabilities from design to launch and applications. Additionally, Rocket Lab is involved in promising Mars exploration projects, including NASA contracts and plans for Mars missions in the late 2020s and 2030s. Despite risks such as ongoing unprofitability and reliance on capital raises, the improved valuation and strong demand position Rocket Lab for multi-year growth.
Rocket Lab Corporation is evolving into a vertically integrated space infrastructure platform, with its Space Systems revenue more than doubling and backlog reaching $2.36 billion. This growth supports sustained revenue and margin expansion, although...
SpaceX stock fell 6% to $131.86, dropping below its $135 IPO price for the first time since June, following the unlocking of 319 million shares. This tranche is part of a staggered release schedule that will free most of the company's shares by 2027,...
Rocket Lab's stock has fallen about 49% from its Q2 peak, erasing earlier gains. The decline follows widening losses due to increased development costs for its Neutron rocket and margin pressure from near-term product mix. Despite these negatives, an...
SpaceX completed its 100th launch of 2026, pushing its Starlink constellation past 11,000 satellites in orbit. In response, the U.S. Space Force awarded five contracts worth $12 million each to companies including L3Harris, AST SpaceMobile, Rocket La...
Rocket Lab reported a Q2 revenue of $234 million and a backlog of $2.36 billion, with recent contract awards exceeding $1 billion. The Space Systems segment generated $189.5 million, reflecting the company's strategy of integrating spacecraft, compon...
